- Home
- WB vs APLS Comparison
WB vs APLS Comparison
Compare WB & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WB | APLS |
|---|---|---|
| Founded | 2009 | 2009 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.7B |
| IPO Year | 2014 | 2017 |
Fundamental Metrics
Financial Performance| Metric | WB | APLS |
|---|---|---|
| Price | $10.66 | $26.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 20 |
| Target Price | $14.00 | ★ $33.89 |
| AVG Volume (30 Days) | 852.5K | ★ 2.2M |
| Earning Date | 11-18-2025 | 10-30-2025 |
| Dividend Yield | ★ 15.34% | N/A |
| EPS Growth | ★ 20.16 | N/A |
| EPS | ★ 1.76 | 0.36 |
| Revenue | ★ $1,740,785,000.00 | $1,016,397,000.00 |
| Revenue This Year | $0.53 | $28.88 |
| Revenue Next Year | $2.38 | N/A |
| P/E Ratio | ★ $6.08 | $66.85 |
| Revenue Growth | N/A | ★ 42.11 |
| 52 Week Low | $7.10 | $16.10 |
| 52 Week High | $12.96 | $35.57 |
Technical Indicators
Market Signals| Indicator | WB | APLS |
|---|---|---|
| Relative Strength Index (RSI) | 61.42 | 62.04 |
| Support Level | $10.45 | $23.69 |
| Resistance Level | $10.90 | $26.24 |
| Average True Range (ATR) | 0.18 | 1.16 |
| MACD | 0.09 | -0.04 |
| Stochastic Oscillator | 73.66 | 89.63 |
Price Performance
Historical ComparisonAbout WB Weibo Corporation
Weibo Corp is a China-based company mainly engaged in the social media advertising business for people to create, discover and distribute content. The company's activities include Advertising and Marketing, which mainly provides a full range of advertising customization and marketing solutions. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The Company's main product is the social platform Weibo.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.